J. Jeong

发表

No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial

Y. Jung, Seho Park, W. Moon, 2022, BMC cancer.

Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR

Yoonjung Kim, S. Ahn, Y. Cha, 2022, NPJ breast cancer.

Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer.

J. Roh, S. Shin, S. Noh, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis.

S. Nam, Joohyun Woo, M. Chung, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group

Seho Park, Jong Won Lee, S. Bae, 2022, Frontiers in Oncology.

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP

Min Hwan Kim, J. Sohn, S. Ahn, 2022, Cancer medicine.

Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.

D. Wickerham, N. Wolmark, E. Mamounas, 2001, Journal of the National Cancer Institute. Monographs.

On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates

Min Hwan Kim, H. Park, Seho Park, 2023, Breast Cancer Research.

Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast Cancer

S. Ahn, B. Son, S. Ahn, 2022, JAMA network open.

Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer

Yoonjung Kim, Kyung-A Lee, S. Ahn, 2022, NPJ breast cancer.

Adding ovarian function suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or resume menstruation after chemotherapy: 8-year follow-up of the randomized ASTRRA trial.

S. Ahn, Y. Jung, Seung Il Kim, 2022, Journal of Clinical Oncology.

Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy.

S. Ahn, Y. Cha, S. Bae, 2023, Radiology.

Intraoperative examination of sentinel lymph nodes by immunohistochemical staining in patients with breast cancer.

K. Oh, Joon Jeong, S. Hong, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Association between HER2 amplification and cetuximab efficacy in patients with RAS wild-type metastatic colorectal cancer

D. Kim, S. Kim, Juyang Kim, 2016 .

Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial

S. Ahn, Y. Jung, S. Im, 2023, Journal of Clinical Oncology.

Variations in (18)F-FDG uptake in breast cancer depending on PET/CT acquisition position.

J. Seok, S. Ahn, J. Jeong, 2016, Clinical radiology.